Skip to main content
OpenTrials
Completed

NCT Number: NCT07745868

Adenoidectomy With or Without Partial Inferior Turbinectomy for Pediatric Nasal Obstruction

Nasal obstruction is a common problem in children and is frequently caused by adenoid hypertrophy with concomitant inferior turbinate hypertrophy, leading to sleep-disordered breathing and reduced quality of life. Although adenoidectomy is the standard treatment, persistent nasal obstruction may occur in some patients due to inferior turbinate enlargement. Recent evidence suggests that combining inferior turbinate reduction with adenoidectomy may provide superior relief of nasal obstruction and improve postoperative outcomes compared with adenoidectomy alone.

The study aims to compare the effectiveness of adenoidectomy alone versus adenoidectomy combined with endoscopic bilateral partial inferior turbinectomy in relieving nasal obstruction and sleep-disordered breathing in children with adenoid and bilateral inferior turbinate hypertrophy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Alazhar university Hopital in Assiut

Asyut, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age : children (9 - 18 years old ) only.
  • Patients with bilateral nasal obstruction or sleep-disordered breathing, and having adenoid hypertrophy diagnosed by nasal endoscopy, with bilateral inferior turbinate hypertrophy investigated by CT and confirmed by endoscopy despite 3 months of medical treatment with intranasal corticosteroid and oral antihistaminic.
  • Sex : both males and females.
  • Patients were selected from the otorhinolaryngology outpatient clinic of Al-Azhar University hospital in Assiut in a consecutive manner.
  • All patients were generally well and fit for surgery.

Exclusion criteria

  • • Patients with recent upper respiratory tract infection.
  • Evidence of any bleeding disorders .
  • Patients with serous otitis media and chronic tonsillitis.
  • patients contraindicated to do adenoidectomy after phoniatric consultation.
  • patients with atrophic rhinitis
  • patients with nasal obstruction due to other causes such as : deviated nasal septum and antrochoanal polyp.
  • Patients with sinonasal pathology like a marked septal deviation or nasal polyposis, and those exhibiting symptoms that could indicate chronic or recurrent rhinosinusitis, such as fever, headaches, facial pain, rhinorrhea, antibiotic requirements, and purulence seen on nasal endoscopy.

Treatment and study plan

Adenoidectomy

Procedure

Adenoidectomy by currattage assisted by suction coagulation

Adenodiectomy and bilateral partial infeiror turbienctomy

Procedure

adenodiectomy by currattage assisted by suction coagulation and bilateral partial inferior turbienctomy

Primary outcomes

  1. operative time

    Time frame: During the procedure

    operative duration in mintues

  2. nasal obstruction

    Time frame: preoperative till 2 months after opertaions

    pre and post operative difeerence of nasal obstruction using nose score

Sponsors and collaborators

Lead sponsor

Al-Azhar University

Other

Registry information

Official study title

The Effect of Adenoidectomy With or Without Endoscopic Bilateral Partial Inferior Turbinectomy on Children With Bilateral Nasal Obstruction

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Aug 4, 2026
Registry last updated
Aug 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.